Product Information

TRIAZOLAM 0.25 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.3011 per EA under NDC 50742064601. Its NADAC has been published 282 times since Mar 31, 2021.

FDA first approved this application on Oct 20, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRIAZOLAM 0.25 MG TABLET

Triazolam
$0.3011per EA
DEA Schedule CIV

Strength

.25 mg/1

NDC

50742064601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TRIAZOLAM

Approval Type

Generic (ANDA)

FDA Application

ANDA214219

FDA Approved

10/20/2020

TE Code

AB

On Market Since

10/20/2020

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for TRIAZOLAM 0.25 MG TABLET has been published 282 times since Mar 31, 2021, and over the history we have for it it has declined 75.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3011 per EA
All-time high$1.3127 (May 12, 2021)
All-time low$0.2380 (Nov 20, 2024)
52-week high$0.3765
52-week low$0.3011
Median price$0.5928
Average price$0.7148
Largest weekly change+51.7% (May 22, 2024)
Weeks tracked282
Tracking sinceMar 31, 2021

Price History

1W

-5.3%

1M

-5.3%

3M

-16.8%

6M

-17.7%

1Y

-20.0%

3Y

-68.7%

5Y

-75.7%

All

-75.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TRIAZOLAM 0.25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRIAZOLAM 0.25 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.3011 per EA (NDC 50742064601), effective Aug 19, 2026.

How has the price of TRIAZOLAM 0.25 MG TABLET changed over time?

Over the history we have for it, the NADAC for TRIAZOLAM 0.25 MG TABLET has declined 75.9%. It has been tracked across 282 weekly CMS publications since Mar 31, 2021.

What are the highest and lowest recorded NADAC prices for TRIAZOLAM 0.25 MG TABLET?

Since Mar 31, 2021, the NADAC for TRIAZOLAM 0.25 MG TABLET has ranged from a low of $0.2380 (Nov 20, 2024) to a high of $1.3127 (May 12, 2021), with a median of $0.5928 per EA.

Are there cheaper alternatives to TRIAZOLAM 0.25 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRIAZOLAM 0.25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TRIAZOLAM 0.25 MG TABLET?

TRIAZOLAM 0.25 MG TABLET (NDC 50742064601) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.